<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Ra Pharmaceuticals Inc — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/ra-pharmaceuticals-inc</link>
    <description>Plain-English explanations of patents assigned to Ra Pharmaceuticals Inc, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 06:05:50 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/ra-pharmaceuticals-inc/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How Synthetic Peptides Block Immune System Overreaction</title>
      <link>https://patentbrief.org/patent/us/10106579/orkambi-lumacaftor-ivacaftor</link>
      <description>A patent describing specific synthetic peptides designed to stop the body&apos;s immune system from attacking healthy cells by blocking a protein called C5.</description>
      <pubDate>Tue, 23 Oct 2018 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/10106579/orkambi-lumacaftor-ivacaftor</guid>
    </item>
  </channel>
</rss>
